Back

Management of statin intolerance in a pharmacy led cardiology innovative medicines optimisation lipid clinic

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Nursing and allied professions - Chronic care Allied Professions in Cardiovascular Care ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mrs Abigail Barrowcliff

Leeds Teaching Hospitals, Leeds (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
The STEPSTONES transition program for adolescents with congenital heart disease is effective in improving patient empowerment: a randomized controlled trial
Associate Professor E. Bratt (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Referrals to palliative care for cardiovascular patients: A 10-year longitudinal retrospective study
Doctor F. Ecarnot (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
Cognitive impairment and low health literacy are associated with poor health outcomes in patients with heart failure
Associate Professor J. Wu (Lexington, US)
Abstract Slides Video
Presentation thumbnail
Patients and healthcare professionals views on injectables for cardiovascular disease
Doctor G. Lee (Cork, IE)
Abstract Slides Video
Presentation thumbnail
Using a co-designed, self-delivered, Avatar-based patient discharge education application to improve acute coronary syndrome patient knowledge
Doctor L. Zhang (Camperdown, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Nursing and allied professions - Chronic care

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Resistance to lipid-lowering therapy with PCSK9 inhibitors: comparative efficacy and clinical implications
thumbnail
Congress Presentation
What’s new on lipid-lowering drugs: from statins to gene editing and beyond
thumbnail
Congress Presentation
Impact of a pharmacist-led clinic in optimising lipid therapy for post-acute coronary syndromes (ACS) in high risk cardiovascular patients.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources